Consistent with previous findings [12, 13], we found that the surface expression of SIGLEC-1 was increased in CD14+ monocytes from SLE patients compared to healthy controls (P = 1.4 × 10− 4; Fig. 2b). Here, CD14 is linked to systemic lupus erythematosus.